Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Adverum Biotechnologies, Inc. | SVP, Genl Counsel, Acting CFO | Performance Based Stock Option (Right to Buy) | 75.3K | Sep 14, 2022 | Direct | ||
Adverum Biotechnologies, Inc. | SVP, Genl Counsel, Acting CFO | Stock Option (Right to Buy) | 42.8K | Sep 14, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADVM | Adverum Biotechnologies, Inc. | Sep 14, 2022 | 2 | $0 | 4 | Sep 16, 2022 | SVP, Genl Counsel, Acting CFO |
ADVM | Adverum Biotechnologies, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | SVP, Genl Counsel, Acting CFO |
ADVM | Adverum Biotechnologies, Inc. | Jun 3, 2022 | 0 | $0 | 3 | Jun 10, 2022 | SVP, Genl Counsel, Acting CFO |